Fundraising FoxARTBIO
Oslo, NO · 9 known investors
Find your way into ARTBIO
Sign up to find every way you can get introduced to ARTBIO
- Your email: who you already know at ARTBIO, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ARTBIO team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
Founders & leadership
Investors · 9
.jpeg){kind=logo}
How we know: B Capital Group's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · the VCSheet dataset · sofinnova.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$132M disclosed across 1 of 2 rounds · 2023–2025
- $132MSeries BJul 2025 · 2 sources
B Capital (lead), Sofinnova Investments (lead), Alexandria Venture Investments, F-Prime, Omega Funds, Qatar Investment Authority, Third Rock Ventures
Source ↗ - Undisclosed amountSeries ADec 2023
Third Rock Ventures (lead), F-Prime Capital, Omega Funds
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does ARTBIO do?
- ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
- Who founded ARTBIO?
- ARTBIO was founded by Roy Larsen, Øyvind Bruland.
- Who are ARTBIO's investors?
- ARTBIO's investors include B Capital Group, B4 Capital, F-Prime Capital, Sofinnova Ventures, Alexandria, B Capital, Omega Funds, Qatar Investment Authority and 1 more.
- How much funding has ARTBIO raised?
- ARTBIO has disclosed $132M raised across 1 of its 2 known rounds.
- Where is ARTBIO headquartered?
- ARTBIO is headquartered in Oslo, NO.